Prevalence of Type 2 Diabetes Mellitus among Hepatitis C Virus-Infected Patients: A Systematic Review and Meta-Analysis
Dubai Diabetes and Endocrinology Journal · 2018 · 24 (1-4) · 29-37
DOI: 10.1159/000493945 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Dubai Diabetes and Endocrinology Journal, online erschienen am 23.10.2018. Verfasst von Sintayehu Ambachew und 4 weiteren Autor:innen. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
The ever-increasing global prevalence of hepatitis C infection is fueling the burden of diabetes mellitus, which exacerbates various complications and may be a cause of death of millions of people. Several studies have reported that hepatitis C virus infection is an important risk factor for the development of diabetes mellitus. However, fragmented studies have reported variable and inconsistent findings regarding the prevalence of type 2 diabetes mellitus among hepatitis C virus-infected patients. Therefore, this meta-analysis aimed to estimate the overall prevalence of type 2 diabetes mellitus among patients infected with hepatitis C virus.
Methods
This systematic review and meta-analysis includes original articles reporting on cohort and cross-sectional studies. A systematic search was performed in PubMed, ScienceDirect, and Google Scholar. A random-effects meta-analysis model was used to estimate the global pooled prevalence of type 2 diabetes mellitus among hepatitis C-infected patients. A sensitivity analysis was conducted to check the stability of the summary estimate. Heterogeneity was assessed using the I2 statistic. A subgroup analysis was also conducted based on geographical region. Funnel plots were used to spot publication bias.
Results
A total of 40 eligible articles reporting data on 14,765 study participants were included in this meta-analysis. The pooled prevalence of type 2 diabetes mellitus among hepatitis C virus-infected patients was 19.67% (95% CI: 17.25, 22.09). The subgroup analysis showed a pooled prevalence of 27.72% (95% CI: 20.79, 34.65) in Africa, 20.73% (95% CI: 17.57, 23.90) in Asia, 16.64% (95% CI: 6.79, 26.49) in North America, and 15.02% (95% CI: 10.66, 19.38) in Europe.
Conclusions
The overall prevalence of type 2 diabetes mellitus among hepatitis C virus-infected patients was considerably higher than in the general population in a global perspective. The highest prevalence was noted in Africa and Asia, followed by North America and Europe. Therefore, early intervention is needed (prevention and early treatment of hepatitis C virus infection) to prevent the development of type 2 diabetes mellitus.
Zitieren
APA
Ambachew, S., Eshetie, S., Geremew, D., Endalamaw, A., & Melku, M. (2018). Prevalence of Type 2 Diabetes Mellitus among Hepatitis C Virus-Infected Patients: A Systematic Review and Meta-Analysis. Dubai Diabetes and Endocrinology Journal, 24(1-4), 29-37. https://doi.org/10.1159/000493945
Vancouver
Ambachew S, Eshetie S, Geremew D, Endalamaw A, Melku M. Prevalence of Type 2 Diabetes Mellitus among Hepatitis C Virus-Infected Patients: A Systematic Review and Meta-Analysis. Dubai Diabetes and Endocrinology Journal. 2018;24(1-4):29-37. doi:10.1159/000493945
BibTeX
@article{Ambachew2018,
author = {Ambachew, Sintayehu and Eshetie, Setegn and Geremew, Demeke and Endalamaw, Aklilu and Melku, Mulugeta},
title = {Prevalence of Type 2 Diabetes Mellitus among Hepatitis C Virus-Infected Patients: A Systematic Review and Meta-Analysis},
journal = {Dubai Diabetes and Endocrinology Journal},
year = {2018},
volume = {24},
number = {1-4},
pages = {29--37},
doi = {10.1159/000493945}
}
EUVIMED